跳转到主要内容

In 2017, Biohaven was in need of clinical pharmacology and pharmacometrics expertise for Nurtec to supplement their drug development team. They engaged with Certara because of our proven experience in clinical pharmacology and pharmacometrics.

Certara was able to fill the gaps and worked closely alongside Biohaven’s scientists to use quantitative methods to advance Nurtec’s path to approval.

Certara Happy Family Sunset Biohaven 1

Certara’s contribution to the drug development program for Nurtec ODT was substantial. 他们的临床药理学代表与 Biohaven 开发团队紧密合作。Certara’s considerable expertise in clinical pharmacology and pharmacometrics and flawless execution supported Nurtec’s clinical development team and helped to prepare the clinical pharmacology NDA components.

Richard Bertz, PhD Vice President, Clinical Pharmacology & Pharmacometrics
Certara Migraine Biohaven 1

Migraine headaches are a debilitating neurological disorder that affects approximately 15% of the adult population in the United States (US), comprising approximately 38 million adults. Migraines rank as the third most prevalent disease worldwide and the seventh highest specific cause of disability worldwide.

我们可为您提供哪些帮助?

立即与我们联系,以讨论如何加快您的计划。

沪ICP备2022021526号

Powered by Translations.com GlobalLink OneLink Software